Journal of Cardiac Failure
Volume 13, Issue 5 , Pages 346-352 , June 2007

Restrictive Filling Pattern is a Powerful Predictor of Heart Failure Events Postacute Myocardial Infarction and in Established Heart Failure: A Literature-Based Meta-Analysis

Received 11 August 2006 ,Revised 23 January 2007 ,Accepted 25 January 2007.

References 

  1. Thom T, et al. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85–e151
  2. Oh JK, et al. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 1997;10:246–270
  3. Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. JACC. 1998;32:865–875
  4. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta stone. JACC. 1997;30:8–18
  5. Whalley GA, Gamble GD, Doughty RN. Restrictive diastolic filling predicts death post acute myocardial infarction: a meta-analysis of prospective studies. Heart 2006;92:1588–94.
  6. Whalley GA, Gamble GD, Doughty RN. The prognostic significance of restrictive diastolic filling associated with heart failure: a meta-analysis. Int J Cardiol 2007;116:70–7.
  7. Garcia-Rubira JC, et al. Abnormal filling pattern of the left ventricle and outcome in acute myocardial infarction. Int J Cardiol. 1997;61:143–149
  8. Nijland F, et al. Prognostic implications of restrictive left ventricular filling in acute myocardial infarction: a serial Doppler echocardiographic study. JACC. 1997;30:1618–1624
  9. Sakata K, et al. Prognostic value of Doppler transmitral flow velocity patterns in acute myocardial infarction. Am J Cardiol. 1997;79:1165–1169
  10. Poulsen SH, Jensen SE, Egstrup K. Longitudinal changes and prognostic implications of left ventricular diastolic function in first acute myocardial infarction. Am Heart J. 1999;137:910–918
  11. Tsai WC, et al. Prognostic value of Doppler-derived mitral deceleration time in postinfarction patients with left ventricular ejection fractions of 35% or more. J Formosan Med Assoc. 1999;98:70–72
  12. Burgess MI, Atkinson P, Ray SG. Restrictive left ventricular filling pattern after myocardial infarction: significance of concomitant preserved systolic function. Echocardiography. 2000;17:659–664
  13. Møller JE, et al. Pseudonormal and restrictive filling patterns predict left ventricular dilation and cardiac death after a first myocardial infarction: a serial color M-mode Doppler echocardiographic study. JACC. 2000;36:1841–1846
  14. Cerisano G, et al. Prognostic implications of restrictive left ventricular filling in reperfused anterior acute myocardial infarction. JACC. 2001;37:793–799
  15. Brzezninska B, et al. [Prognostic value of a model using restricted left ventricular filling for prediction of developing heart failure after myocardial infarction]. Przeglad Lekarski. 2002;59:583–586
  16. Karvounis HI, et al. Evaluation of a Doppler-derived index combining systolic and diastolic left ventricular function in acute myocardial infarction. Angiology. 2004;55:21–28
  17. Kinova E, Kozhuharov H. Left ventricular diastolic filling patterns as predictors of heart failure after myocardial infarction: a colour M-mode Doppler study. Hellen J Cardiol. 2004;45:23–31
  18. Møller JE, et al. Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy. Am Heart J. 2004;147:494–501
  19. Belardinelli R, et al. Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy. Clinical and prognostic implications. Circulation. 1995;91:2775–2784
  20. Pozzoli M, et al. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. Circulation. 1997;95:1222–1230
  21. Bettencourt P, et al. Predictors of prognosis in patients with stable mild to moderate heart failure. J Cardiac Failure. 2000;6:306–313
  22. Dini FL, et al. Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathy. Am J Cardiol. 2002;89:518–523
  23. Whalley GA, et al. Pseudonormal mitral filling pattern predicts hospital re-admission in patients with congestive heart failure. JACC. 2002;39:1787–1795
  24. Hellermann JP, et al. Heart failure after myocardial infarction: a review. Am J Med. 2002;113:324–330
  25. Emanuelsson H, Karlson BW, Herlitz J. Characteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failure. Eur Heart J. 1994;15:761–768
  26. Ali AS, et al. Clinical predictors of heart failure in patients with first acute myocardial infarction. Am Heart J. 1999;138:1133–1139
  27. Altun A, et al. Heart failure during first inferior acute myocardial infarction. Coron Artery Dis. 1999;10:455–458
  28. Vaur L, et al. Epidemiology of myocardial infarction in France: therapeutic and prognostic implications of heart failure during the acute phase. Am Heart J. 1999;137:49–58
  29. Nicod P, et al. Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction. Am J Cardiol. 1988;61:1165–1171
  30. Lewis EF, et al. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. J Am Coll Cardiol. 2003;42:1446–1453
  31. The Capricorn I. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385–1390
  32. Pfeffer MA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992;27:669–677
  33. Pitt B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309–1321
  34. Stewart S, et al. Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?. Eur Heart J. 2001;22:209–217
  35. Cowie MR, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart. 2000;83:505–510
  36. Blackledge HM, Tomlinson J, Squire IB. Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993–2001. Heart. 2003;89:615–620
  37. Stewart S, et al. Poles apart, but are they the same? A comparative study of Australian and Scottish patients with chronic heart failure. Eur J Heart Failure. 2001;3:249–255
  38. Stewart S, et al. More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Failure. 2001;3:315–322
  39. Schaufelberger M, et al. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden: data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J. 2004;25:300–307
  40. Lee DS, et al. Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000. Am J Med. 2004;116:581–589
  41. Appleton CP, et al. Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease. Additional value of analyzing left atrial size, left atrial ejection fraction and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction. JACC. 1993;22:1972–1982
  42. Nishimura RA, et al. Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. JACC. 1996;28:1226–1233
  43. Yamamoto K, et al. Determination of left ventricular filling pressure by Doppler echocardiography in patients with coronary artery disease: critical role of left ventricular systolic function. JACC. 1997;30:1819–1826
  44. Pozzoli M, et al. Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure with and without mitral regurgitation. JACC. 1996;27:883–893
  45. Yu CM, et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J. 1996;17:1694–1702
  46. Margulies KB, et al. Physiological significance of early deceleration time prolongation in asymptomatic elderly subjects. J Card Failure. 1999;5:92–99
  47. Akioka K, et al. Prognostic value of Doppler transmittal flow patterns and cardiac natriuretic peptides in patients with chronic congestive heart failure admitted for episodes of acute decompensation. Heart Vessels. 2000;15:53–60
  48. Patrianakos AP, et al. Restrictive filling pattern is associated with increased humoral activation and impaired exercise capacity in dilated cardiomyopathy. Eur J Heart Failure. 2004;6:735–743
  49. Fisher C, et al. N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart. 2003;89:879–881
  50. Isnard R, et al. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure. Am Heart J. 2003;146:729–735
  51. Anand ISM, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation. 2003;107:1278–1283
  52. Gwechenberger M, et al. Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure. J Heart Lung Transplant. 2004;23:839–844
  53. Latini R, et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J. 2004;25:292–299
  54. Logeart D, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. JACC. 2004;43:635–641
  55. de Groote P, et al. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. JACC. 2004;43:1584–1589
  56. Temporelli PL, et al. Reversible restrictive left ventricular diastolic filling with optimized oral therapy predicts a more favorable prognosis in patients with chronic heart failure. JACC. 1998;31:1591–1597
  57. Pinamonti B, et al. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. JACC. 1997;29:604–612
  58. Temporelli PL, et al. Doppler-derived mitral deceleration time as a strong prognostic marker of left ventricular remodeling and survival after acute myocardial infarction: results of the GISSI-3 echo substudy. JACC. 2004;43:1646–1653

 Dr. Jithendra Somaratne is supported by the Greenlane Educational and Research Fund and the Douglas Goodfellow Medical Research Fellowship from the Auckland Medical Research Foundation. Dr. Gillian Whalley is currently the National Heart Foundation of New Zealand Senior Fellow.

PII: S1071-9164(07)00011-5

doi: 10.1016/j.cardfail.2007.01.010

Journal of Cardiac Failure
Volume 13, Issue 5 , Pages 346-352 , June 2007

Article Tools

* Image Usage & Resolution